Pain
From the Journals
Only 1.5% of individuals at high risk of opioid overdose receive naloxone
“Clinicians can address this gap by regularly prescribing naloxone to eligible patients.”
Conference Coverage
Outpatient program successfully tackles substance use and chronic pain
MILWAUKEE – Pain and substance use issues are frequently comorbid in the military health population.
Conference Coverage
Medical cannabis relieved pain, decreased opioid use in elderly
Medical cannabis was an effective and well-tolerated treatment in an elderly cohort of patients with chronic pain.
News from the FDA/CDC
CDC warns against misuse of opioid-prescribing guideline
Officials at the Centers for Disease Control and Prevention are advising against misapplication of the agency’s guideline on opioid prescribing....
Conference Coverage
In chronic pain, catastrophizing contributes to disrupted brain circuitry
MILWAUKEE – Brief cognitive-behavioral therapy holds promise to restore functional connectivity disrupted by pain and catastrophizing.
Conference Coverage
In pain treatment, racial bias common among physician trainees
MILWAUKEE – Most residents and fellows who demonstrated racial bias did not report that race factored into treatment decisions.
FDA/CDC
Alvogen issues recall for mislabeled fentanyl patches
The recall was issued because a small number of cartons labeled as containing 12 mcg/h patches contained 50 mcg/h patches.
Conference Coverage
‘Fibro-fog’ confirmed with objective ambulatory testing
MILWAUKEE – Objective smartphone-based testing tracked with subjective assessment of cognitive function in fibromyalgia.
FDA/CDC
FDA to expand opioid labeling with instructions on proper tapering
The label changes are intended to be used when both the clinician and patient have agreed to reduce the opioid dosage.
Conference Coverage
NIH’s HEAL initiative seeks coordinated effort to tackle pain, addiction
MILWAUKEE – The two aims of research under the initiative are to improve treatments for misuse and addiction, and to enhance pain management.
Conference Coverage
In sickle cell disease, opioid prescribing starts early, study finds
MILWAUKEE – It’s not clear what parents of children with sickle cell disease are told about when and how to administer opioid analgesia.